Trading Ideas

COVID-19 has put several little-known pharma companies on the map. Going hand in hand with these nano-caps’ pursuit of coronavirus solutions, hopeful investors have sent the small players’ shares to previously unimaginable heights.Vaxart (VXRT) might be the purest example of this phenomenon. At the start of the year, the vaccine specialist’s market cap stood at $17.39 million, with each share going for $0.34. Fast forward to July 29, and the biotech is valued at $1.2 billion, with shares changing hands for $11 apiece, an increase of an amazing 3,135%.Vaxart is not an outlier, as several other names have also recorded …read more […]

The CEOs of Amazon, Apple, Facebook and Google sat for a 5-hour grilling before the House Judiciary Committee, with dramatically different results for each company. …read more […]

Until recently, shares of Bionano Genomics (BNGO) had been on an almost constant downward trend, declining by 90% since August 2018. However, sentiment appears to have improved as evidenced by a gain of 50% over the past month.According to Oppenheimer analyst Kevin DeGeeter, there’s still a long way up from here. The 5-star analyst reiterated an Outperform (i.e. Buy) rating on BNGO shares along with a $1.50 price target. The implication for investors? Mighty upside potential of a further 100%. (To watch DeGeeter’s track record, click here)For starters, the heart of the bullish case for Bionano is its role in …read more […]

(Bloomberg) — Samsung Electronics Co. reported earnings that beat estimates and said demand for memory chips is likely to recover in the second half of the year, driven by new smartphones and gaming consoles.Net income increased to 5.5 trillion won ($4.6 billion) in the three months ended June, the company said in a filing on Thursday, compared with the 4.9 trillion won average of estimates compiled by Bloomberg. Samsung had reported preliminary numbers earlier this month that showed operating profit rose 23%.The world’s largest maker of memory chips and smartphones had warned of a second-quarter sales slump in its consumer …read more […]

On Wednesday, the four major tech CEOS – Mark Zuckerberg of Facebook, Jeff Bezos of Amazon, Sundar Pichai of Alphabet, and Tim Cook of Apple – testified before Congress on an antitrust probe. Yahoo Finance’s Final Round panel discusses what was heard from the four major CEOs and what it could mean moving forward for their companies. …read more […]

On Sunday, Moderna (MRNA) disclosed it had been awarded an extra $472 million from the Biomedical Advanced Research and Development Authority (BARDA) to further support the development of mRNA-1273, its experimental COVID-19 vaccine. The new award follows a $483 million grant provided by BARDA in April, which means Moderna has now received a total of $955 million in funding from the U.S. government.The award coincides with the initiation of Moderna’s Phase 3 study of mRNA-1273. The study began on Monday with the dosing of the first patients in the 30,000-participant study across 87 trial sites. If all goes according to …read more […]

(Bloomberg) — Silver’s biggest monthly rally since 1980 has mainly been a story of strong demand. Investors are seeking shelter from pandemic turmoil and negative rates while industrial demand for the metal recovers in some parts of the world.But here’s another reason to be bullish on silver: Supplies are set to shrink too.Peruvian and Mexican mines that make up almost 40% of world supply shut en masse earlier this year as the pandemic hit. While much of the industry is ramping back up, some mines have had to close again as Covid-19 cases surge. The Silver Institute now predicts a …read more […]

Apple CEO Tim Cook faced pointed questions from the House Judiciary Committee’s Subcommittee on Antitrust, Commercial, and Administrative Law on Wednesday, with members pointing to the cut Apple takes from app developers in its App Store. …read more […]

Who needs to be at The Oxford Club’s Private Wealth Seminar in Park City, Utah?
Thanks to technology and life in a COVID-19 world…
We can watch Karim’s presentation on demand!
It’s so engaging, even I crashed the party.
Check it out here!

And get this, Karim and I made a bold promise to War Room members last year.
We guaranteed 252 winning trades in one year or less… and we put big money on the line – betting $5 million we would hit it.
And guess what? We hit that number just eight months in!
And we haven’t slowed down… The War Room is averaging 10 winners …read more […]

Note: Today’s Safety Net comes from Assistant Research Manager Andrew Hubbarth. Chief Income Strategist Marc Lichtenfeld is currently returning from the 2020 Private Wealth Seminar in Park City, Utah, where he livestreamed to Oxford Club Members about the best opportunities in today’s market.

The popularity of traditional cigarettes has been in decline for years, but Altria‘s (NYSE: MO) dividend continues to rise as the company diversifies into new vices.
The days of the Marlboro Man and product placement in “cool” movie scenes are mostly gone – so Altria has shifted much of its attention to vaping and even marijuana.
But Altria still controls …read more […]

…read more […]

Stock futures were slightly higher Wednesday evening as market participants continued to digest the Federal Reserve’s latest monetary policy statement, which was largely viewed as dovish. Investors looked ahead to the first report on US second-quarter GDP Thursday morning, along with more data on weekly jobless claims. …read more […]

…read more […]

Fed Chairman Jerome Powell said Wednesday that the economy appears to have slowed since COVID-19 cases picked back up in mid-June. …read more […]

The coronavirus pandemic has pushed many consumers to do their shopping online. According to the U.S. Mint, this has resulted in a shortage of coins. …read more […]